Bristol Myers Squibb
This role leads the scientific and preclinical laboratory components of late-stage immune-oncology programs, driving strategy through mechanism of action studies, differentiation, and combination rationale. The position supports translational development activities by delivering data on biomarkers, patient selection, and resistance mechanisms to advance clinical development. It requires collaboration with internal and external research teams to maximize the potential of current and future therapeutics.
Headquarters
Lawrence Township, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers prescription medicines for serious diseases, with a focus on oncology, hematology, immunology, cardiovascular, neuroscience, and other therapeutic areas. The company operates in the pharmaceutical and biotechnology industry, serving patients worldwide through research, development, manufacturing, and commercialization of innovative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bristol Myers Squibb.
14% above the average for this role
Post Doctoral Scholar-Comprehensive Cancer Center
The Ohio State University
Associate Scientist
Syngene International Limited
Senior Scientist I / II – Translational Immuno‑Oncology Research (OTR)
Novartis
Senior Scientist, Immunology
MSD
Translational Scientist
ImmunEdge, Inc
Translational Sciences Research Associate (6-month contract role)
PharmaEssentia